Aromatase inhibitors associated osteonecrosis of jaw: signal refining to identify pseudo safety signals. (Record no. 30837701)

MARC details
000 -LEADER
fixed length control field 01542 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518094731.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202103s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2210-7711
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s11096-020-01018-z
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Neha, Reddy
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20210304
245 00 - TITLE STATEMENT
Title Aromatase inhibitors associated osteonecrosis of jaw: signal refining to identify pseudo safety signals.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. International journal of clinical pharmacy
Date of publication, distribution, etc. Apr 2020
300 ## - PHYSICAL DESCRIPTION
Extent 721-727 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adverse Drug Reaction Reporting Systems
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aromatase Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bisphosphonate-Associated Osteonecrosis of the Jaw
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diphosphonates
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element False Positive Reactions
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Jaw Diseases
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Osteonecrosis
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacovigilance
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States Food and Drug Administration
General subdivision standards
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Beulah, Elsa
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Anusha, Bellapu
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vasista, Sharma
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stephy, Chacko
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Subeesh, Viswam
773 0# - HOST ITEM ENTRY
Title International journal of clinical pharmacy
Related parts vol. 42
-- no. 2
-- p. 721-727
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s11096-020-01018-z">https://doi.org/10.1007/s11096-020-01018-z</a>
Public note Available from publisher's website

No items available.